← Back to Search

Other

Sedentary Individuals - Acute Moderate-Intensity Exercise for Aerobic Exercise

Phase 1 & 2
Recruiting
Led By Jennifer L Gay, PhD
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-test and post-test (immediately following exercise)
Awards & highlights

Study Summary

This trial aims to see how the body changes in response to exercise among college students. They are comparing physically active and inactive students to see how their biomarkers and mental health differ. Multiple students are involved

Who is the study for?
This trial is for healthy college students aged 18-34 who can pass a basic physical activity readiness questionnaire. Participants should either be sedentary or active, meeting exercise guidelines. They must be willing to do blood tests and a 12-minute elliptical workout, and they need to speak English.Check my eligibility
What is being tested?
The study aims to compare how moderate-intensity exercise on an elliptical machine affects biomarkers in physically active versus sedentary college students. It also looks at the impact of such activity on their mental health.See study design
What are the potential side effects?
Since this trial involves moderate exercise, potential side effects may include muscle soreness, fatigue, and short-term changes in heart rate or blood pressure during the activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-test and post-test (immediately following exercise)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-test and post-test (immediately following exercise) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ammonia
C-reactive protein
Cortisol
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sedentary Individuals - Acute Moderate-Intensity ExerciseExperimental Treatment1 Intervention
8 minutes of elliptical exercise at a moderate intensity based on heart rate reserve. There will be a 2-minute warm-up and 2-minute cool down period in addition to the 8 minutes at moderate-intensity.
Group II: Active Individuals - Acute Moderate-Intensity ExerciseExperimental Treatment1 Intervention
8 minutes of elliptical exercise at a moderate intensity based on heart rate reserve. There will be a 2-minute warm-up and 2-minute cool down period in addition to the 8 minutes at moderate-intensity.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of GeorgiaLead Sponsor
102 Previous Clinical Trials
34,706 Total Patients Enrolled
Jennifer L Gay, PhDPrincipal InvestigatorUniversity of Georgia
2 Previous Clinical Trials
49 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the inclusion criteria for this research study open to individuals aged 55 and above?

"Individuals aged between 18 and 34 are eligible to participate as per the study's age requirements."

Answered by AI

Is this medical study actively seeking participants at the moment?

"As per clinicaltrials.gov, this ongoing medical investigation is actively seeking potential participants. The trial debut was on March 11th, 2024, and the latest update occurred on March 5th of the same year."

Answered by AI

Am I eligible to be a part of this medical study?

"Prospective participants must engage in aerobic physical activity and fall within the age range of 18 to 34 years old to meet eligibility criteria for this medical research. The trial aims to enroll approximately 56 individuals."

Answered by AI

What is the uppermost limit for participant enrollment in this research endeavor?

"Yes, the details outlined on clinicaltrials.gov confirm that patient recruitment is ongoing for this particular trial. The initial posting date of the clinical trial was March 11th, 2024, with the most recent update noted on March 5th, 2024. A total of 56 participants are being sought from a single designated site."

Answered by AI
~28 spots leftby Jun 2024